Your browser doesn't support javascript.
loading
Diagnosis of bipolar disorders and body mass index predict clustering based on similarities in cortical thickness-ENIGMA study in 2436 individuals.
McWhinney, Sean R; Abé, Christoph; Alda, Martin; Benedetti, Francesco; Bøen, Erlend; Del Mar Bonnin, Caterina; Borgers, Tiana; Brosch, Katharina; Canales-Rodríguez, Erick J; Cannon, Dara M; Dannlowski, Udo; Diaz-Zuluaga, Ana M; Dietze, Lorielle; Elvsåshagen, Torbjørn; Eyler, Lisa T; Fullerton, Janice M; Goikolea, Jose M; Goltermann, Janik; Grotegerd, Dominik; Haarman, Bartholomeus C M; Hahn, Tim; Howells, Fleur M; Ingvar, Martin; Kircher, Tilo T J; Krug, Axel; Kuplicki, Rayus T; Landén, Mikael; Lemke, Hannah; Liberg, Benny; Lopez-Jaramillo, Carlos; Malt, Ulrik F; Martyn, Fiona M; Mazza, Elena; McDonald, Colm; McPhilemy, Genevieve; Meier, Sandra; Meinert, Susanne; Meller, Tina; Melloni, Elisa M T; Mitchell, Philip B; Nabulsi, Leila; Nenadic, Igor; Opel, Nils; Ophoff, Roel A; Overs, Bronwyn J; Pfarr, Julia-Katharina; Pineda-Zapata, Julian A; Pomarol-Clotet, Edith; Raduà, Joaquim; Repple, Jonathan.
Afiliação
  • McWhinney SR; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Abé C; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Alda M; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Benedetti F; Vita-Salute San Raffaele University, Milan, Italy.
  • Bøen E; Psychiatry and Psychobiology Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Del Mar Bonnin C; Unit for Psychosomatics/CL Outpatient Clinic for Adults, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Borgers T; Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • Brosch K; Department of Psychiatry, University of Münster, Münster, Germany.
  • Canales-Rodríguez EJ; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Cannon DM; FIDMAG Germanes Hospitalàries Research Foundation, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • Dannlowski U; Clinical Neuroimaging Laboratory, Centre for Neuroimaging & Cognitive Genomics (NICOG), NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Diaz-Zuluaga AM; Department of Psychiatry, University of Münster, Münster, Germany.
  • Dietze L; Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Elvsåshagen T; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Eyler LT; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Fullerton JM; Division of Clinical Neuroscience, Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Goikolea JM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Goltermann J; Department of Psychiatry, University of California, San Diego, La Jolla, California, USA.
  • Grotegerd D; Desert-Pacific MIRECC, VA San Diego Healthcare, San Diego, California, USA.
  • Haarman BCM; Neuroscience Research Australia, Randwick, New South Wales, Australia.
  • Hahn T; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • Howells FM; Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • Ingvar M; Department of Psychiatry, University of Münster, Münster, Germany.
  • Kircher TTJ; Department of Psychiatry, University of Münster, Münster, Germany.
  • Krug A; Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Kuplicki RT; Department of Psychiatry, University of Münster, Münster, Germany.
  • Landén M; Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • Lemke H; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Liberg B; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Lopez-Jaramillo C; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Malt UF; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Martyn FM; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
  • Mazza E; Laureate Institute for Brain Research, Tulsa, Oklahoma, USA.
  • McDonald C; Department of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
  • McPhilemy G; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Meier S; Department of Psychiatry, University of Münster, Münster, Germany.
  • Meinert S; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Meller T; Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Melloni EMT; Unit for Psychosomatics/CL Outpatient Clinic for Adults, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Mitchell PB; Department of Neurology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Nabulsi L; Clinical Neuroimaging Laboratory, Centre for Neuroimaging & Cognitive Genomics (NICOG), NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Nenadic I; Vita-Salute San Raffaele University, Milan, Italy.
  • Opel N; Psychiatry and Psychobiology Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ophoff RA; Clinical Neuroimaging Laboratory, Centre for Neuroimaging & Cognitive Genomics (NICOG), NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Overs BJ; Clinical Neuroimaging Laboratory, Centre for Neuroimaging & Cognitive Genomics (NICOG), NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Pfarr JK; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Pineda-Zapata JA; Department of Psychiatry, University of Münster, Münster, Germany.
  • Pomarol-Clotet E; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Raduà J; Center for Mind, Brain and Behavior (CMBB), University of Marburg and Justus Liebig University Giessen, Marburg, Germany.
  • Repple J; Vita-Salute San Raffaele University, Milan, Italy.
Bipolar Disord ; 24(5): 509-520, 2022 08.
Article em En | MEDLINE | ID: mdl-34894200
ABSTRACT

AIMS:

Rates of obesity have reached epidemic proportions, especially among people with psychiatric disorders. While the effects of obesity on the brain are of major interest in medicine, they remain markedly under-researched in psychiatry.

METHODS:

We obtained body mass index (BMI) and magnetic resonance imaging-derived regional cortical thickness, surface area from 836 bipolar disorders (BD) and 1600 control individuals from 14 sites within the ENIGMA-BD Working Group. We identified regionally specific profiles of cortical thickness using K-means clustering and studied clinical characteristics associated with individual cortical profiles.

RESULTS:

We detected two clusters based on similarities among participants in cortical thickness. The lower thickness cluster (46.8% of the sample) showed thinner cortex, especially in the frontal and temporal lobes and was associated with diagnosis of BD, higher BMI, and older age. BD individuals in the low thickness cluster were more likely to have the diagnosis of bipolar disorder I and less likely to be treated with lithium. In contrast, clustering based on similarities in the cortical surface area was unrelated to BD or BMI and only tracked age and sex.

CONCLUSIONS:

We provide evidence that both BD and obesity are associated with similar alterations in cortical thickness, but not surface area. The fact that obesity increased the chance of having low cortical thickness could explain differences in cortical measures among people with BD. The thinner cortex in individuals with higher BMI, which was additive and similar to the BD-associated alterations, may suggest that treating obesity could lower the extent of cortical thinning in BD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article